Trial Profile
Phase II study comparing nab-paclitaxel with pemetrexed in patients with stage IIIB/IV non-small-cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 19 May 2016 New trial record